Elevation of Lipid Components Influences Coronary Disease Newsletter Article 20 February 2013 Pages: 2 - 3
A Glance at Present and Future Prospects in Ocular Drug Delivery Newsletter Article 20 February 2013 Pages: 3 - 3
The Activity of Calcium Antagonists in Essential Hypertension Newsletter Article 20 February 2013 Pages: 4 - 4
Citalopram: depression not elevated with this serotonin reuptake inhibitor Newsletter Article 20 February 2013 Pages: 5 - 5
Arotinolol: this α- and β-blocker lowers intraocular pressure as effectively as timolol Newsletter Article 20 February 2013 Pages: 5 - 5
Ketanserin: improves peripheral circulation during anaesthesia … Newsletter Article 20 February 2013 Pages: 5 - 6
Pinacidil: oral administration has a more favourable pharmacokinetic profile Newsletter Article 20 February 2013 Pages: 6 - 6
Imipenem: a first-line antibacterial for urinary tract infections? Newsletter Article 20 February 2013 Pages: 6 - 7
Single-dose Nebulised Salbutamol in Children With Acute Asthma Newsletter Article 20 February 2013 Pages: 8 - 9
Ticarcillin in Combination with Tobramycin or Latamoxef? Newsletter Article 20 February 2013 Pages: 11 - 12
Improving Amoxycillin’s Chances Against Gonorrhoea Newsletter Article 20 February 2013 Pages: 14 - 14
Salbutamol Powder by ‘Rotahaler’ Improved Pulmonary Function Newsletter Article 20 February 2013 Pages: 16 - 16
Kinetic Profiles of Slow Release Theophylline Products Newsletter Article 20 February 2013 Pages: 16 - 17
Thymopentin: world first introduction of this immunomodulator by Italfarmaco in Italy Newsletter Article 20 February 2013 Pages: 19 - 19
Fenofibrate: an antihyperlipidaemic on the market in numerous countries Newsletter Article 20 February 2013 Pages: 19 - 20